Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 64 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
TRIMEDIK from Beauraing, company number BE0736912661, closed financial year 2025 with a result of € -823 after tax. For that financial year TRIMEDIK recorded a gross margin of € 49,269 and equity of € 149,455. Compared with financial year 2024, the result moved from € -22,937 to € -823. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ 149,455
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -823
▲ 96 % less loss than in 2024
Profit after tax over the fiscal year.
€ 21,854
▼ 19% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -50,545.
Debts at end 2025
€ 572,915
▼ 6% vs 2024
€ 33,770 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 45,034 | € 50,453 | € 27,550 | € 49,269 | ▲ 79% |
| Profit after taxes | € -3,729 | € 102 | € -22,937 | € -823 | ▲ € 22,114 |
| Equity | € 173,114 | € 173,216 | € 150,279 | € 149,455 | ▼ 1% |
| Total debts | € 675,651 | € 643,207 | € 610,802 | € 573,062 | ▼ 6% |
| Cash | € 31,999 | € 40,987 | € 27,028 | € 21,854 | ▼ 19% |
| Land & buildings | € 815,959 | € 774,564 | € 733,168 | € 699,753 | ▼ 5% |
| Retained profit | € -26,886 | € -26,784 | € -49,721 | € -50,545 | ▼ € 823 |
| Bank debt | € 674,424 | € 641,930 | € 609,027 | € 572,915 | ▼ 6% |
| Balance sheet total | € 848,765 | € 816,423 | € 761,081 | € 722,518 | ▼ 5% |
Key figures of TRIMEDIK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to TRIMEDIK?
What happened at TRIMEDIK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 823. Source: NBB ↗
- New establishment in Beauraing. KBO
- Start of the company according to the CBE. KBO
In short
From € 3,729 loss in 2022 to € 823 loss in 2025.
Best year ever: 2023, with € 102 profit.
Management
Behind TRIMEDIK are Manuel Motte, Pierre Leclercq and Joëlle Hercot. Manuel Motte is also behind MEDIMOTTE généraliste.
Directors
According to the 2025 annual accounts
Pierre Leclercq
Director
Joëlle Hercot
Director
Establishments
Establishment units
Physical locations of this company
rue de Snaye,Pd 1
5574 Beauraing
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0736.912.661
- VAT number
- BE 0736.912.661
- Registered office
- rue de Snaye,Pd 1, 5574 Beauraing
- Names & denominations
- TRIMEDIK
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 October 2019
- Peppol
- Not registered
- Contact
- [email protected] +32472893787